首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   116289篇
  免费   9276篇
  国内免费   1143篇
耳鼻咽喉   978篇
儿科学   1441篇
妇产科学   396篇
基础医学   5253篇
口腔科学   571篇
临床医学   3335篇
内科学   3739篇
皮肤病学   625篇
神经病学   3882篇
特种医学   1196篇
外国民族医学   2篇
外科学   3274篇
综合类   4900篇
现状与发展   8篇
一般理论   4篇
预防医学   1142篇
眼科学   92048篇
药学   2296篇
  43篇
中国医学   505篇
肿瘤学   1070篇
  2023年   1842篇
  2022年   3411篇
  2021年   4046篇
  2020年   3488篇
  2019年   2916篇
  2018年   3587篇
  2017年   2775篇
  2016年   3149篇
  2015年   3632篇
  2014年   6146篇
  2013年   5859篇
  2012年   6633篇
  2011年   6952篇
  2010年   5335篇
  2009年   4770篇
  2008年   5427篇
  2007年   5607篇
  2006年   5027篇
  2005年   4647篇
  2004年   4336篇
  2003年   4157篇
  2002年   3785篇
  2001年   3788篇
  2000年   3364篇
  1999年   3039篇
  1998年   958篇
  1997年   735篇
  1996年   566篇
  1995年   590篇
  1994年   539篇
  1993年   555篇
  1992年   2036篇
  1991年   1886篇
  1990年   1739篇
  1989年   1533篇
  1988年   1430篇
  1987年   764篇
  1986年   233篇
  1985年   392篇
  1984年   490篇
  1983年   490篇
  1982年   459篇
  1981年   452篇
  1980年   465篇
  1979年   411篇
  1978年   362篇
  1977年   244篇
  1976年   276篇
  1974年   235篇
  1973年   258篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Survey of ophthalmology》2023,68(5):920-928
There remains limited agreement regarding the efficacy and safety of different antivascular endothelial growth factor (anti-VEGF) agents for the management of polypoidal choroidal vasculopathy (PCV). Our meta-analysis compares different anti-VEGF agents for PCV treatment. Ovid MEDLINE, EMBASE, and Cochrane Library were systematically searched from January 2000 to July 2022. We included articles comparing the efficacy and safety of different anti-VEGF agents, specifically bevacizumab (BEV), ranibizumab (RAN), aflibercept AFL), and brolucizumab (BRO), for patients with PCV. 10,440 studies were identified, 122 underwent full-text review, and seven were included. One study was a randomized trial, and six were observational studies. Ranibizumab and aflibercept were associated with a similar best-corrected visual acuity (BCVA) at the last visit in three observational studies (P = 0.10), similar retinal thickness at the last visit in two observational studies (P = 0.85). One observational study comparing BEV versus RAN found comparable outcomes for final BCVA, retinal thickness, and polyp regression. One randomized trial on BRO versus AFL found comparable outcomes for improvement in BCVA, while anatomical outcomes favored BRO. The available evidence suggests that final BCVA is comparable across different anti-VEGF agents, however, further investigation is warranted due to paucity of evidence.  相似文献   
3.
4.
5.
6.
7.
Diabetic retinopathy (DR) is one of the most important complications of diabetes. Accurate segmentation of DR lesions is of great importance for the early diagnosis of DR. However, simultaneous segmentation of multi-type DR lesions is technically challenging because of 1) the lack of pixel-level annotations and 2) the large diversity between different types of DR lesions. In this study, first, we propose a novel Poisson-blending data augmentation (PBDA) algorithm to generate synthetic images, which can be easily utilized to expand the existing training data for lesion segmentation. We perform extensive experiments to recognize the important attributes in the PBDA algorithm. We show that position constraints are of great importance and that the synthesis density of one type of lesion has a joint influence on the segmentation of other types of lesions. Second, we propose a convolutional neural network architecture, named DSR-U-Net++ (i.e., DC-SC residual U-Net++), for the simultaneous segmentation of multi-type DR lesions. Ablation studies showed that the mean area under precision recall curve (AUPR) for all four types of lesions increased by >5% with PBDA. The proposed DSR-U-Net++ with PBDA outperformed the state-of-the-art methods by 1.7%-9.9% on the Indian Diabetic Retinopathy Image Dataset (IDRiD) and 67.3% on the e-ophtha dataset with respect to mean AUPR. The developed method would be an efficient tool to generate large-scale task-specific training data for other medical anomaly segmentation tasks.  相似文献   
8.
9.
10.
《Journal of AAPOS》2022,26(5):242.e1-242.e6
BackgroundPeripapillary hyperreflective ovoid masslike structures (PHOMS) are now considered a common cause of pseudopapilledema in the pediatric population.MethodsThe medical records of all patients ≤18 years of age with PHOMS, confirmed on optical coherence tomography, seen at single pediatric neuro-ophthalmology clinic between 2017 and 2021 were reviewed retrospectively.ResultsA total of 47 patients (35 females), with median age of 12.7 years at initial visit, were included. Of these, 24 (51%) of patients were optometry referrals. Headache was a common symptom. PHOMS were present bilaterally in all patients and were 360° around the disk in 57 of 94 eyes (61%). Patients with elevated intracranial pressure were more likely to have a reduction in the size of PHOMS at follow-up (P = 0.0133). Of the 47, 40 (85%) had diagnostic neuroimaging as a part of their papilledema workup. The retinal nerve fiber layer was thicker in patients with concomitant papilledema rather than optic disk drusen (P = 0.002) and compared with patients with PHOMS alone (P = 0.00051).ConclusionsPediatric patients with PHOMS may be referred because their clinical appearance can be suggestive of papilledema. In our study cohort, PHOMS were bilateral and frequently occurred concurrently with other ophthalmic conditions.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号